ALADDIN is a multidisciplinary effort. 🤝 Each one of our partners has its expertise, from synthetic and #molecularbiology to mathematical #modelling & #microfluidics. By bringing their know-how together, we can reach excellent results! 💥 aladdin-project.eu/consortium/

Fresh from the press! 🗞️ This review by Paul et al., published in Nature Reviews Cancer in May, summarises therapeutic antibodies’ approaches to target cancer cells: 🔬 Mechanisms of action 🔬 Structural basis for target specificity 🔬 Clinical applications nature.com/articles/s4156…

✅ Therapeutic #antibodies have potential in cancer treatment. ⛔ Their discovery is slow & expensive. 💡ALADDIN accelerates therapeutic antibody discovery by combining technologies related to antibody generation & identification into one platform! aladdin-project.eu

🚀 Breaking barriers in cancer treatment 🚀 ALADDIN helps take a leap forward! Our research project integrates diverse technologies to streamline therapeutic #antibody discovery. With our partners, we're making strides towards eradicating cancer! 🙌 aladdin-project.eu

In the #ALADDINproject, we are developing a platform to make therapeutic #antibody discovery more efficient, that is… 🏃 Faster 💰 More affordable 💻 More automated Read more about the project: aladdin-project.eu

Nanobodies have huge promise for treating malignancies! 🔬 Researchers from @BCMHouston have discovered that #nanobodies could neutralise norovirus, a virus that can be life-threatening for certain population groups, like infants & the elderly 🦠 drugtargetreview.com/article/113247…

Integrated platform for therapeutic antibody discovery 🚀 ALADDIN is a research project that enhances the process of discovering therapeutic antibodies, making it faster and more affordable than current solutions. Visit our website to find out more: aladdin-project.eu

Food allergies pose health risks for millions of people globally🤒 Researchers from @NKU1919 show nanobodies’ advantages over traditional antibodies in food allergen detection, such as macadamia, peanut, lupin & milk proteins 🥜🫘🥛 Via Phys.org: phys.org/news/2024-06-c…

Eight partners, one common goal 🤝 Our consortium, with top organisations from different parts of Europe and beyond, holds expertise in… 🦠 Synthetic and molecular biology 🖥️ Mathematical modelling 🤖 AI 💧 Microfluidics …and much more! aladdin-project.eu/consortium/

Reasons to use nanobodies for cancer treatment 🔬, as explained by Jumapili et al. in this article of European Journal of Immunology: 🤏Small size ⚖️High stability & solubility 🔄Fast elimination from circulation via the kidneys The list goes on! Find out more: onlinelibrary.wiley.com/doi/full/10.10…

ALADDIN makes therapeutic #antibody discovery more efficient through: 🔍 Target identification 🧫 Antibody discovery ⚙️ Optimisation ✅ Preclinical validation The project outcomes can lead to improved #cancer treatment! #EUeic #EICPathfinder aladdin-project.eu

The field of therapeutic antibodies is constantly evolving ⏩ The Antibody Society keeps track of antibody therapeutics approved or in regulatory review in 🇪🇺 and 🇺🇲 Take a look at the current list: antibodysociety.org/resources/appr…

ALADDIN wouldn’t exist without the collaboration of 8 top international organisations: 🇪🇸 Centro Nacional de Biotecnología (CSIC) 🇵🇹 INL 🇪🇸 Instituto de Salud Carlos III (ISCIII) 🇪🇸 IIS-FJD (Fundación Jiménez Díaz) 🇸🇪 Linköpings universitet 🇮🇱 Hebrew University 🇬🇷 @InCellia 🇪🇸 @ZirkaInnoTech aladdin-project.eu/consortium

Taking therapeutic antibody discovery to new heights! 🚀 The ALADDIN platform aims to accelerate nanobody identification and their preclinical validation for human cancer. 🔬 Discover the power of nanobodies in cancer treatment and our approach: aladdin-project.eu/about/